renal course

We are very pleased to announce the next interactive, online, webinar, ‘virtual classroom’ teaching modules from the Education Committee of The Transplantation Society.

This program is designed as an advanced curriculum in Renal Transplantation to be made available to members of TTS world wide free of charge. This curriculum will be administered through online webinars from June 2015 at monthly intervals. Experts on the key topics in the field of transplantation will present the interactive webinars. The courses will be designed incorporating the new learning and teaching techniques as described in the TTS Distinguished Educator course. The target audience for this series is doctors and trainees, who have a keen interest in advancing their knowledge in renal transplantation. This will enable them to practice the state-of-the--art medicine anywhere in the world. This series will be CME accredited and those who complete the entire series will be awarded the TTS Certificate in Advanced Renal Transplantation.

Nithya Krishnan

Course Co-Director
Consultant Transplant Nephrologist
University Hospital Coventry &
Warwickshire NHS Trust
Coventry, United Kingdom

Medhat Askar

Course Co-Director
Medical Director
Allogen Laboratories
Cleveland Clinic
Cleveland, OH, United States

TUESDAY, MARCH 22, 2016 - 8AM MONTREAL TIME (1PM BRUSSELS)

RECIPIENT ASSESSMENT AND EVALUATION

DANIEL ABRAMOWICZ

Presenter

Dr. DANIEL ABRAMOWICZ, MD, PhD
Nephrology Department
Antwerp University Hospital
Antwerp, Belgium

COLM MAGEE

Moderator

Dr. COLM MAGEE, MD
Consultant in Nephrology and Kidney Transplantation
Beaumont Hospital Kidney Centre
Dublin, Ireland

IMPORTANT

The online certificate site will be available the end of the day March 22, 2015 through May 22, 2016. After that date, the site will be removed and certificates will no longer be available.  If you need a CME certificate, you must complete the evaluation and certificate process prior to that date; otherwise you will forfeit your credit for the course.

To view the recording of the presentation click here (You must be logged into the wesbite)

To claim your CME credits click here (You must be logged into the wesbite)

Biography

Daniel Abramowicz, MD, PhD, is professor of nephrology and since 2013 head of the department of Nephrology-Hypertension of the Antwerp University Hospital and University of Antwerp (Belgium). He was formerly the head of the renal transplantation program at the Université Libre de Bruxelles, Brussels, Belgium where more than 2500 renal transplantation have been performed.

Dr. Abramowicz has completed a doctoral thesis in 1994, on "Induction of transplantation tolerance in mice". He is author and co-author of more than 200 articles dealing mainly with immunosuppressive regimens in renal transplantation, that have been published among others in Transplantation, Journal of the American Society of Nephrology, American Journal of Transplantation, and Kidney International.

Dr. Abramowicz is Subject Editor for Transplantation for Nephrology, Dialysis and Transplantation. He was a member of the expert group that issued the European Best Practice Guidelines on renal transplantation in 2000 and 2002, and is now member of the European Renal Best Practice advisory board of the ERA-EDTA.

(http://www.european-renal-best-practice.org). He has chaired a working party commissioned by the European Renal Best Practice advisory board to update the European guidelines on renal transplantation. He is chairman of the Descartes ERA-EDTA working group on Transplantation (http://www.era-edta.org/descartes/descartes.htm).

Learning Objectives:

  1. Should we actively screen for presence of malignancy in kidney transplant candidates? Is presence or history of malignancy a contraindication to kidney transplantation?
  2. Under which conditions can HIV infected patients be enrolled on the waiting list?
  3. Should focal segmental glomerulosclerosis (FSGS) as underlying cause of end-stage kidney disease preclude waitlisting for transplantation and does it influence graft and patient survival post-transplantation?
  4. Does pre-transplant tobacco smoking in patients influence patient or graft survival?
  5. Should obesity preclude waitlisting for kidney transplantation and is there a difference in outcomes post-transplantation between those with and without obesity?
  6. How should screening for potential cardiovascular disease in the potential recipient be done in a cost-effective way?
  7. When and for which indications should native nephrectomy be performed in kidney transplant candidates awaiting kidney transplantation?
  8. What are the indications for an additional haemodialysis session in the recipient immediately before the transplantation procedure?
  9. In kidney transplant recipients, what are the effects of using a JJ stent at the time of operation on outcomes?
  10. At what level of GFR should a patient be pre-emptively transplanted?

After the webinar, the attendees should have learned the main issues to be assessed before wait-listing a patient with regards to malignancies, cardiovascular diseases, recurrence of native kidney disease, necessity for pre-transplant nephrectomy, listing of HIV patients, necessity to dialyse the patient pre-Tx, and how to deal with obesity and smoking pre-transplant.

1.

Necessary Hardware and Software

2.

Acknowledgement of Commercial Support, Satisfactory Completion, Accreditation Statement, Credit Designation Statement, Note for CME Regarding Europeans, Note for CME Regarding Canadians, Program Learning Objectives, Faculty Disclosure

3.

Bibliographic Sources

4.

Policy on Privacy and Confidentiality

5.

Copyright

Necessary Hardware and Software

Windows

  • 1.4GHz Intel® Pentium® 4 or faster processor (or equivalent) for Microsoft® Windows 7, Windows 8 or Windows 8.1
  • Windows 8.1 (32-bit/64-bit), Windows 8 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
  • 512MB of RAM (1GB recommended) for Windows 7 or Windows 8
  • Microsoft Internet Explorer 8 or later; Mozilla Firefox; Google Chrome
  • Adobe® Flash® Player 11.2+

Mac OS

  • 1.83GHz Intel Core™ Duo or faster processor
  • 512MB of RAM (1GB recommended)
  • Mac OS X 10.8, 10.9, 10.10
  • Mozilla Firefox; Apple Safari; Google Chrome
  • Adobe Flash Player 11.2+

Linux

  • Ubuntu 14.04; Red Hat Enterprise Linux 6; OpenSuSE 13.1
  • No Add-in support for Linux. Users on Linux can attend meetings in the browser.
  • Google Chrome
  • Adobe Flash Player 11.2+

Mobile

  • Apple supported devices: iPhone 5S, iPhone 5, iPhone 4S, iPad with Retina display, iPad 3, iPad 2, iPad mini, and iPod touch (4th & 5th generations)
  • Apple supported OS versions summary: iOS 6 and higher
  • Android supported devices: Motorola DROID RAZR MAXX, Motorola Atrix, Motorola Xoom, Samsung Galaxy Tab 2 10.1, Samsung Galaxy S3 & S4, Nexus 7 tablet
  • Android supported OS versions summary: 2.3.4 and higher

If you have never attended a Connect Pro meeting before:

Test your connection: http://dlp.adobeconnect.com/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/go/connectpro_overview

Acknowledgement of Commercial Support

No commercial support was received for this enduring material activity.

Satisfactory Completion

Participants must complete pass the posttest with 80% or better and complete an evaluation form in order to receive a certificate of completion.  Your chosen sessions must be attended in their entirety.  Partial credit of individual sessions is not available.

Accreditation Statement

The Transplantation Society (TTS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

The Transplantation Society designates this enduring material activity for 1.0 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note for CME regarding Europeans

Mutual recognition of credits between the American Medical Association and the UEMS-European Accreditation Council for CME. See the link below for more information.

http://www.ama-assn.org/ama/pub/education-careers/continuing-medical-education/physicians-recognition-award-credit-system/other-ways-earn-ama-pra-category/international-programs/uemseaccme-credit-conversion.page?

Note for CME regarding Canadians

See link below for the AMA agreement with the Royal College of Physicians and Surgeons of Canada regarding CME credit conversion.

http://www.ama-assn.org/ama/pub/education-careers/continuing-medical-education/physicians-recognition-award-credit-system/other-ways-earn-ama-pra-category/international-programs/credit-through-rcpsc.page?

Program Learning Objectives

  1. Identify, explain, analyze the key clinical and physiological concepts of kidney transplantation
  2. Be able to relate and apply the key concepts of kidney transplantation in the day-to-day clinical practice.
  3. Employ a systematic approach in responding to diverse clinical scenarios related to kidney transplantation.
  4. Formulate appropriate management plans for clinical scenarios kidney transplantation
  5. Develop and modify these skills to be able to contribute to the education and professional development of junior colleagues.

Faculty Disclosure

All faculty participating in the continuing medical education programs sponsored by The Transplantation Society are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).

We acknowledge the potential presence of limitations on information, including, but not limited to: data that represents ongoing research; interim analysis; preliminary data; unsupported opinion; or approaches to care that, while supported by some research studies, do not represent the only opinion or approach to care supported by research.

Financial Relationship Key

G-Grant/Research Support
C-Consultant/Scientific Advisor  
S-Speaker ’s Bureau
E-Employee
O-Other
N-Nothing to disclose

Resolution Key

R1-Restricted to Best Available Evidence & ACCME content validation statement
R2-Removed/Altered Financial Relationship 
R3-Altered Control
R4-Peer Review with 2nd method of resolution

The list below includes all individuals in control of content for this CME activity

Role Last Name First Name Disclosure Resolution
Planner Askar Medhat NTD N/A
Planner Krishnan Nithya NTD N/A
Planner Colarusso Roberto NTD N/A
Speaker Abramowicz Daniel NTD N/A
CME Consultant Xiaong Blia NTD N/A
Planner Woodbury Darren NTD N/A

Bibliographic Sources

No advanced reading required. A list of references and further reading will be provided during the webinar.

Policy on Privacy and Confidentiality

The Transplantation Society (TTS) respects the privacy of visitors to its website. TTS strongly believes that our visitors must be assured that information provided online is used responsibly and appropriately. To protect online privacy, the TTS has implemented the following policy.

NOTE: THIS POLICY APPLIES ONLY TO ONLINE COLLECTION OF INFORMATION.

  • Information We Collect and How We Use It
    • TTS collects two types of information about you when you visit our website: personal information (including, by way of example only, your name, address, telephone number, e-mail address, demographic information and credit card information) and non-personal, aggregate information (such as information regarding the pages on our site that you have visited and your IP address).
  • Personally Identifiable Information:
    • TTS does not collect personally identifiable information about you unless you choose to provide it. Personal information is collected through membership application and inquiry processes and through other services or procedures that the TTS may implement from time to time. You are not required to submit any personally identifiable information in order to access information in the public areas of our website.
  • To gain access to membership and other personalized features on the TTS website, users are asked to register and provide limited personal information. This information is submitted voluntarily. If you do not wish for us to have your personal information, please do not provide it.

TTS uses information voluntarily submitted by visitors in the following ways:

  • TTS Services and Products.
    • Generally, TTS uses data collected to improve its own web content; to identify popular areas of the website; to respond to visitor and member needs, interests and preferences and to develop new products and services.
  • Credit Card Information:
    • TTS does not disclose credit card information provided by its members and customers except to third parties that assist with processing credit card purchases. When and customers choose to pay by using their credit cards, TTS submits the information needed to obtain payment to the appropriate clearinghouse. The credit card numbers are not stored on our servers.
  • Non-Personally Identifiable Information:
    • TTS collects non-personally identifiable, aggregate information from visitors to our website. This non-personally identifiable information includes but is not limited to the number of hits per page, cookies, referrers, IP address, or other ‘environmental’ variables. The TTSd oes not link non-personally identifiable information with personally identifiable information. Aggregate data are only used for internal and marketing purposes and do not provide any personally identifiable information.
  • Cookies:
    • Cookies are files that contain information created by a web server that can be stored on a User’s hard disk for future use (“persistent” cookie). Cookies transmit non-personal information back to the web site. TTS uses cookies in its virtual meeting rooms to facilitate automated activity. We may also use cookies to help us track traffic on our site. This information may be aggregated in an anonymous manner, and will help us better tailor our site and provide you with offers that we think may be of interest to you. Cookies are not used to disseminate significant information about users over the Internet or to analyze any information that users have knowingly or unknowingly provided. When a user logs in, the system will ask whether the user approves of the attachment of a cookie. Users may opt out of accepting a “persistent” cookie, however, the user will need to login each time they visit the site.

CHOICE

  • Notification of Changes:
    • If we decide to change our privacy policy, we will notify you and post those changes on our web site so you will always be aware of what information we collect, how we use it and under what circumstances we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify you by way of an e-mail. You will then have a choice as to whether or not we use your information in this different manner. We will use information in accordance with the privacy policy in effect at the time that the information was collected.
  • Choices Available to the User:
  • TTS provides the following choices regarding the use of your information:
    - You may choose not to provide us with any personal information.
    - You may set your browser to not accept cookies, or to warn you when a cookie is being placed on your computer. If you choose not to accept cookies, however, your ability to navigate this web site may be hindered.

Security:

  • You understand and agree that “perfect” security does not exist anywhere, including on the Internet. When you send your credit card information to us over our website, we encrypt this information between your computer and our server. Other information you send to this site, including email messages, will not be encrypted unless we advise you otherwise. The TTS website is protected by a firewall and monitored for security.

Third Party Links:

  • This web site may contain links to other sites. PLEASE BE AWARE THAT WE ARE NOT RESPONSIBLE FOR THE CONTENT OR PRACTICES OF ANY OTHER SITES.
    We encourage our users to read the privacy statements of each and every web site that they visit. This privacy statement applies solely to the TTS website.

Legal Disclaimer:

  • The TTS website is designed to provide users with educational activities, scientific and meeting information, current societal news, public policy information and other needs for transplant professionals. This information is not the same as retaining experts in these fields for advice. Nothing contained in this website is to be considered as the rendering of legal, medical, professional or other advice for specific cases, and users are responsible for obtaining such advice from their own physicians. The information contained on this site is intended for educational, background and informational purposes only.

February 2, 2013

Copyright

The Transplantation Society 2016

Official Sections of The Transplantation Society

cts

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi